Walker K, Reeve A, Bowes M, Winter J, Wotherspoon G, Davis A, Schmid P, Gasparini F, Kuhn R, Urban L
Novartis Pharma AG, Nervous System Research, CH-4002, Basle, Switzerland.
Neuropharmacology. 2001;40(1):10-9. doi: 10.1016/s0028-3908(00)00114-3.
Previous studies have demonstrated that the metabotropic glutamate receptor subtype 5 (mGlu5 receptor) is expressed in the cell bodies of rat primary afferent neurones. We have further investigated the function and expression of mGlu5 receptors in primary afferent neurones, and their role in inflammatory nociception. Freund's complete adjuvant-induced inflammatory hyperalgesia of the rat hind paw was significantly reduced by intraplantar, but not by intracerebroventricular or intrathecal microinjection of the selective mGlu5 receptor antagonist, 2-methyl-6-(phenylethynyl)-pyridine (MPEP). Pharmacological comparison in vivo of the nociceptive effects of glutamate, and ionotropic and metabotropic glutamate (mGlu) receptor agonists applied to the rat hind paw, indicated that group I mGlu receptor agonists induce a dose-dependent decrease in paw withdrawal threshold (mechanical hyperalgesia). Group I mGlu agonist-induced hyperalgesia was inhibited by co-microinjection of MPEP, but not by the mGlu1 receptor antagonist (S)-4-carboxy-phenylglycine (4-CPG). Carrageenan-induced inflammatory hyperalgesia was inhibited by pre-treatment of the inflamed hind paw with MPEP, but not following MPEP injection into the contralateral hind paw. Dorsal horn neurones receiving peripheral nociceptive and non-nociceptive afferent input were recorded in anaesthetized rats following microinjection of CHPG into their peripheral receptive fields. CHPG significantly increased the frequency and duration of firing of dorsal horn wide dynamic range (WDR) neurones and this activity was prevented by co-administration of CHPG and MPEP into their receptive fields. Immunohistochemical experiments revealed the co-expression of mGlu5 receptor protein and betaIII tubulin in skin from naive rats, indicating the constitutive expression of mGlu5 receptors on peripheral neurones. Double-labelling of adult rat DRG cells with mGlu5 receptor and vanilloid receptor subtype 1 antisera also supports the expression of mGlu5 receptors on peripheral nociceptive afferents. These results suggest that mGlu5 receptors expressed on the peripheral terminals of sensory neurones are involved in nociceptive processes and contribute to the hyperalgesia associated with inflammation.
先前的研究表明,代谢型谷氨酸受体5(mGlu5受体)在大鼠初级传入神经元的细胞体中表达。我们进一步研究了mGlu5受体在初级传入神经元中的功能和表达,以及它们在炎性伤害感受中的作用。弗氏完全佐剂诱导的大鼠后爪炎性痛觉过敏,通过足底注射选择性mGlu5受体拮抗剂2-甲基-6-(苯乙炔基)-吡啶(MPEP)可显著减轻,但脑室内或鞘内微量注射则无效。对谷氨酸、离子型和代谢型谷氨酸(mGlu)受体激动剂作用于大鼠后爪的伤害性效应进行体内药理学比较,结果表明I组mGlu受体激动剂可引起剂量依赖性的爪撤离阈值降低(机械性痛觉过敏)。I组mGlu激动剂诱导的痛觉过敏可被与MPEP共同微量注射所抑制,但不能被mGlu1受体拮抗剂(S)-4-羧基苯甘氨酸(4-CPG)抑制。角叉菜胶诱导的炎性痛觉过敏可被用MPEP预处理发炎的后爪所抑制,但在对侧后爪注射MPEP则无效。在麻醉大鼠中,向其外周感受野微量注射CHPG后,记录接受外周伤害性和非伤害性传入输入的背角神经元。CHPG显著增加背角广动力范围(WDR)神经元的放电频率和持续时间,并且将CHPG和MPEP共同注入其感受野可阻止这种活动。免疫组织化学实验显示,mGlu5受体蛋白与βIII微管蛋白在未处理大鼠的皮肤中共表达,表明mGlu5受体在外周神经元上组成性表达。用mGlu5受体和香草酸受体亚型1抗血清对成年大鼠背根神经节细胞进行双重标记,也支持mGlu5受体在外周伤害性传入纤维上的表达。这些结果表明,感觉神经元外周终末上表达的mGlu5受体参与伤害感受过程,并促成与炎症相关的痛觉过敏。